CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 35 enrolled
Drug / intervention
AUDICOR then LifeVest then AUDICORdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02825966
NCT02825966N/ACompleted
CompareCT.gov

Heart Sounds Measurement Using the Wearable Cardioverter Defibrillator (HS-WCD): Study Protocol

Zoll Medical Corporation·interventional·Posted Jul 7, 2016·Updated Dec 2, 2020

In Brief

A clinical study evaluating AUDICOR then LifeVest then AUDICOR for Heart Failure. Completed, enrolled 35 participants across 1 site.

Detailed Summary

A prospective, validation study to evaluate the data accuracy of heart sounds recorded by the LifeVest® Wearable Cardioverter Defibrillator (WCD). These data will be compared with the heart sounds data recorded by an FDA-cleared device AUDICOR AM device.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 7, 2016
Enrollment StartFeb 1, 2016
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.0 years ago

Interventions

AUDICOR then LifeVest then AUDICORdevice

Wearable Cardioverter Defibrillator to record acoustic cardiograph signals.